Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Aug;14(8):447-456.
doi: 10.1038/nrcardio.2017.36. Epub 2017 Mar 23.

Cardiovascular effects of electronic cigarettes

Affiliations
Review

Cardiovascular effects of electronic cigarettes

Neal L Benowitz et al. Nat Rev Cardiol. 2017 Aug.

Abstract

Cardiovascular safety is an important consideration in the debate on the benefits versus the risks of electronic cigarette (EC) use. EC emissions that might have adverse effects on cardiovascular health include nicotine, oxidants, aldehydes, particulates, and flavourants. To date, most of the cardiovascular effects of ECs demonstrated in humans are consistent with the known effects of nicotine. Pharmacological and toxicological studies support the biological plausibility that nicotine contributes to acute cardiovascular events and accelerated atherogenesis. However, epidemiological studies assessing Swedish smokeless tobacco, which exposes users to nicotine without combustion products, generally have not found an increased risk of myocardial infarction or stroke among users, but suggest that nicotine might contribute to acute cardiovascular events, especially in those with underlying coronary heart disease. The effects of aldehydes, particulates, and flavourants derived from ECs on cardiovascular health have not been determined. Although ECs might pose some cardiovascular risk to users, particularly those with existing cardiovascular disease, the risk is thought to be less than that of cigarette smoking based on qualitative and quantitative comparisons of EC aerosol versus cigarette smoke constituents. The adoption of ECs rather than cigarette smoking might, therefore, result in an overall benefit for public health.

PubMed Disclaimer

Conflict of interest statement

Competing interests statement

N.L.B. has been a consultant to GlaxoSmithKline and Pfizer, pharmaceutical companies that market medications to aid smoking cessation, and has served as a paid expert witness in litigation against tobacco companies. J.B.F. declares no competing interests.

Figures

Figure 1
Figure 1. Tobacco combustion products present in a conventional cigarette
Cigarette smoke consists of a complex mixture of combustion products, including >7,000 chemicals. A single puff of cigarette smoke contains 1 × 1017 free radicals. The oxidizing chemicals present in the gas phase of tobacco smoke are believed to be the main contributors to atherogenesis and thrombogenesis.
Figure 2
Figure 2. Components of an electronic cigarette (EC)
The cartridge holds the e-liquid, which contains propylene glycol or vegetable glycerine, nicotine, and flavourings. When heated to high temperatures, as can occur with the use of advanced EC devices, propylene glycol can form thermal dehydration products such as acetaldehyde, formaldehyde, and propylene oxide, whereas vegetable glycerine can generate acrolein and glycidol.
Figure 3
Figure 3. Overview of mechanisms by which electronic cigarette use might cause acute cardiovascular events
Solid lines indicate known pathways. Dashed lines indicate pathways of concern, but for which there are no empirical data for confirmation.

References

    1. Farsalinos KE, Poulas K, Voudris V, Le Houezec J. Electronic cigarette use in the European Union: analysis of a representative sample of 27 460 Europeans from 28 countries. Addiction. 2016;111:2032–2040. - PubMed
    1. Syamlal G, Jamal A, King B, Mazurek J. Electronic cigarette use among working adults — United States, 2014. MMWR Morb Mortal Wkly Rep. 2016;65:557–561. - PubMed
    1. Britton J, Arnott D, McNeill A, Hopkinson N. Nicotine without smoke-putting electronic cigarettes in context. BMJ. 2016;353:i1745. - PubMed
    1. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med. 2016;4:116–128. - PMC - PubMed
    1. U.S. Department of Health and Human Services. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General. NCBI. 2010 http://www.ncbi.nlm.nih.gov/books/NBK53017/pdf/BookshelfNBK53017.pdf. - PubMed

MeSH terms